Glass-based coatings on biomedical implants: a state-of-the-art review by Baino, F. & Verné, E.
04 August 2020
POLITECNICO DI TORINO
Repository ISTITUZIONALE
Glass-based coatings on biomedical implants: a state-of-the-art review / Baino, F.; Verné, E.. - In: BIOMEDICAL
GLASSES. - ISSN 2299-3932. - ELETTRONICO. - 3(2017), pp. 1-17.
Original
Glass-based coatings on biomedical implants: a state-of-the-art review
default_article_editorial
Publisher:
Published
DOI:10.1515/bglass-2017-0001
Terms of use:
openAccess
Publisher copyright
-
(Article begins on next page)
This article is made available under terms and conditions as specified in the  corresponding bibliographic description in
the repository
Availability:
This version is available at: 11583/2669745 since: 2017-04-26T09:42:26Z
De Gruyter Open
© 2017 F. Baino and E. Verné, published by De Gruyter Open.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
Biomed. Glasses 2017; 3:1–17
Review Open Access
Francesco Baino* and Enrica Verné
Glass-based coatings on biomedical implants: a
state-of-the-art review
DOI 10.1515/bglass-2017-0001
Received Nov 14, 2016; revised Mar 22, 2017; accepted Apr 02, 2017
Abstract: Bioactive glasses, invented by Prof. Larry L.
Hench in the late 1960s, have revolutionized the field of
biomaterials as they were shown to tightly bond to both
hard and soft living tissues and to stimulate cells towards
a path of regeneration and self-repair. However, due to
their relatively poor mechanical properties (brittleness,
low bending strength and fracture toughness), they are
generally unsuitable for load-bearing applications. On the
other hand, bioactive glasses have been successfully ap-
plied as coatings on the surface of stronger/tougher sub-
strates to combine adequate mechanical properties with
high bioactivity and, in some cases, additional extra-
functionalities (e.g. antibacterial properties, drug release).
After giving a short overview of the main issues concern-
ing the fabrication of glass coatings, this review provides
a state-of-the-art picture in the field and specifically dis-
cusses the development of bioactive and hierarchical coat-
ings on 3Dporous scaffolds, joint prostheses,metallic sub-
strates (e.g. wires or nails) for orthopedic fixation, poly-
meric meshes and sutures for wound healing, ocular im-
plants and percutaneous devices.
Keywords: Bioactive glass; Coating; Tissue engineering
1 Introduction and crucial aspects
of bioactive glass coating
fabrication
Bioactive glasses are a special subset of biocompatible
ceramics which are able to strongly bond to living tis-
*Corresponding Author: Francesco Baino: Institute of Materials
Physics and Engineering, Applied Science and Technology Depart-
ment, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129
Torino, Italy; Email: francesco.baino@polito.it; Tel.: +39 011 090
4668; Fax: +39 011 090 4624
Enrica Verné: Institute of Materials Physics and Engineering, Ap-
plied Science and Technology Department, Politecnico di Torino,
Corso Duca degli Abruzzi 24, 10129 Torino, Italy
sues (primarily bone) creating a stable interface [1] and
to trigger a range of biological responses such as tis-
sue regeneration and angiogenesis while degrading over
time [2, 3]. These fascinating properties are related to a
time-dependent modification of glass surface upon expo-
sure to physiological environment. According to the clas-
sical mechanism of bioactivity proposed by Hench [4], the
glass surface forms a biologically active layer of nano-
crystalline hydroxyapatite (HA) that provides the bond-
ing interface with host tissues while the dissolution prod-
ucts (e.g. Ca2+ and silicate ions) stimulate the cells to pro-
duce new tissue. The first bioactive glass was developed
by Hench et al. in the late 1960s and belonged to the
SiO2-Na2O-CaO-P2O5 quaternary system (45S5 Bioglassr)
[5]; since then, many other silicate, borate and phosphate
glass compositions have been proposed for a wide range
of biomedical applications in contact to both hard and
soft tissues, as recently reviewed elsewhere [6–8]. How-
ever, due to their poor mechanical properties (especially
tensile strength and fracture toughness), bioactive glasses
alone cannot be used for structural purposes wheremetal-
lic alloys are still thematerials of choice. Two valuable op-
tions to solve this problem involve either the combination
of the glass with a fracture-tough phase, such as ametal or
a polymer, to produce a composite [9], or the application
of the glass as a coating on a mechanically stronger and
tougher substrate [10].
In the biomedical field, coatings have been used in a
variety of applications to modify the surface of implants
and, in some cases, to create an entirely new surface that
gives the implant additional properties which are quite
different from those of the uncoated device [11]. Bioac-
tive coatings are important for orthopaedic and dental im-
plants: in fact, while the metals alone tend to be encap-
sulated with fibrous tissue after implantation, bioactive
glasses have the potential to improve the stability of de-
vices by bonding them to the host bone and, furthermore,
can protect the substrate from corrosion, thereby avoid-
ing the release of potentially toxic metal ions in vivo [12].
However, the nano-crystalline HA layer that forms on the
surface of bioactive glasses is the result of a dissolution
process. From a general viewpoint, bioactive glasses are
by nature biodegradable according to various dissolution
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Table 1: Overview of the most common bioactive glass compositions used to manufacture coatings on biomedical implants (listed in order
of apparition in the main text).
Glass name Synthesis Composition (mol.%)
45S5
Bioglassr
Melt-derived 46.1SiO2-26.9CaO-24.4Na2O-2.6P2O5
CEL2 Melt-derived 45SiO2-26CaO-15Na2O-3P2O5-4K2O-7MgO
61S31C Sol-gel 60.8SiO2-30.9CaO-5.8Na2O-2.4P2O5
58S Sol-gel 60SiO2-36CaO-4P2O5
A/W Melt-derived SiO2-CaO-P2O5-MgO (apatite- and wollastonite-containing glass-ceramic)
64S Sol-gel 64SiO2-31CaO-5P2O5
MBG
(80S15C)
EISAa 80SiO2-15CaO-5P2O5
SCNA Melt-derived 57SiO2-34CaO-6Na2O-3Al2O3
S50P3 Melt-derived 50SiO2-30CaO-14Na2O-3P2O5-2MgO-1Al2O3
S57A7 Melt-derived 57SiO2-30CaO-6Na2O-7Al2O3
S50B2 Melt-derived 50SiO2-35CaO-7Na2O-6P2O5-2B2O3
Biovetror Melt-derived (46-53)SiO2-(9-20)CaO-(7-24)Na2O-(0.1-2)MgO-(4-8)P2O5-(2-8)K2O-(0.1-2)Al2O3
52S Melt-derived 52SiO2-30.5CaO-9.8Na2O-6.2P2O5-1.5CaF2
2Ag-60S Sol-gel 60SiO2–34CaO–4P2O5–2Ag2O
3Zn-42S Melt-derived 41.7SiO2-36.3CaO-5.2Na2O-4.7P2O5-1.3K2O-7.8MgO-3ZnO
5Cu-MBG EISAa 80SiO2-10CaO-5P2O5-5CuO
a Evaporation-induced self-assembling; a mesoporous glass with pore channels of few nanometres is obtained.
rates that depend on the material formulation and envi-
ronmental pH; therefore, a highly bioactive coating may
degrade over time causing instability of the prosthetic im-
plant in the long term. This is probably the major rea-
sonwhy the clinical application of bioactive glass coatings
is still limited and other bioceramics, such as thermally-
sprayed HA which is osteconductive and non-resorbable,
have been preferred by surgeons for a long time [13].
Another important issue about bioactive glass coat-
ings concerns their thermal properties: when a coating
is applied, the thermal expansion coefficient (TEC) of
the glass should match that of the substrate to prevent
the glass pulling away from the base implant upon pro-
cessing [10]. The TEC of the well-known 45S5 Bioglassr
(15×10−6∘C−1) is significantly higher than that of tita-
nium alloys (about 9×10−6 ∘C−1) and alumina (about
8×10−6∘C−1), which are commonly used to fabricate or-
thopaedic and dental implants: therefore, the need has
emerged to develop new glass formulations with a more
suitable TEC for use as coating materials. In this regard,
bioactive glasses belonging to the SiO2-CaO-MgO-Na2O-
K2O-P2O5 system have been widely investigated to match
the TEC of the Ti6Al4V alloy [14–16]. Partial replacement
of Na2O and CaO with K2O and MgO, respectively, was the
most common strategy to design and adjust the TEC of
the glass in a controlled way [14]. B2O3 can be also added
to the glass formulation to decrease the TEC, although
borosilicate glasses show a higher tendency towards dis-
solution in aqueous media (including biological fluids)
compared to silicate materials [17]. Using multiple glass
layers of different compositions has been also proposed to
achieve a good compromise among thermal behaviour, op-
timal dissolution rate and osteointegration [14].
From a technological viewpoint, slurry-dipping, ther-
mal spraying and sputtering are well-established and rel-
atively easy processes to produce homogeneous bioactive
glass coatings on flat substrates [12]; on the contrary, the
fabrication of coatings on the surface of “real” implants
with complex 3D geometries is a great challenge for mate-
rials scientists. Therefore, increasing interest has emerged
in the last years to adapt, improve or modify the available
processing techniques, as well as to develop new ones,
in order to effectively apply bioactive glass coatings on
curved, irregular and porous medical devices. This article
provides a picture of the state of the art in the field, includ-
ing the latest research efforts and achievements. Table 1
collects all the glasses mentioned in the text which have
beenused for the fabrication of coatings on scaffolds, pros-
theses and medical implants.
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Table 2: Overview of glass-based coatings on polymeric, ceramic or metallic scaffolds for bone tissue engineering.
Coating
material
Scaffold material Method of application Coating function Referencesa
45S5
Bioglassr
PDLLA Dipping, EPD Improved bioactivity [18, 19]
Polyurethane Dipping Improved bioactivity [20]
SiC EPD + firing Improved bioactivity [27]
CEL2 Polyurethane Dipping Improved bioactivity,
mechanical reinforcement
[21]
61S31C (sol) Polyurethane EPD on the sol Positive replica of the
polymeric template
[22]
58S Alumina/zirconia
composite
Dipping + firing Improved bioactivity [26]
Bovine HA Prolonged dipping + firing Mechanical reinforcement [29]
A/W HA Dipping + firing Improved bioactivity,
improved mechanical
properties
[28]
64S/gelatin
/PCL
Magnesium Freeze-drying Improved bioactivity,
reduced biodegradability
of Mg scaffold
[31]
58S/PCL Biphasic calcium
phosphate
Dipping Improved mechanical
properties
[30]
SBA-15 Wollastonite-containing
glass-ceramic
Dipping + calcination Controlled drug release [35]
MCM-41 SiO2-CaO-K2O-derived
glass-ceramic
Dipping + calcination Controlled drug release [36, 38]
Fluoroapatite-containing
glass-ceramic
Dipping + calcination Controlled drug release [37]
45S5 Bioglassr Dipping + calcination Controlled drug release [39]
80S15C Wollastonite-containing
glass-ceramic (SCNA)
EPD + calcination Improved bioactivity [43]
β-TCP Spin coating + calcination Improved bioactivity and
bone-forming ability
[44]
MBG/PLGA CaSiO3 Dipping Mechanical reinforcement,
improved bioactivity,
controlled drug release
[46]
a References follows numbering in the main text.
2 Coatings on porous scaffolds for
bone tissue engineering
Biomaterials are often designed and processed to act as
three-dimensional (3D) scaffolds which support tissue
growth and safely dissolve once they have performed their
function, thereby leaving the body to remodel the tissue
to its natural form. Since the early 2000s, glass-coated
porous scaffolds have increasingly attracted the interest of
researchers working in the field of bone tissue engineer-
ing in the attempt to impart key extra-functionalities to
the polymeric or ceramic base material, such as improved
bioactivity and/or drug release ability. In the case of poly-
meric scaffolds, the presence of a glass coating can also
contribute to mechanically reinforce the structure and ad-
just the resorption of the polymer matrix [9]. Table 2 sum-
marizes the studies dealing with the deposition of bioac-
tive glass-based coatings on the surface and struts of 3D
porous scaffolds.
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Figure 1: Glass-based coatings applied on the struts of 3D porous scaffolds: (a) CEL2-coated polyurethane foam (dipping procedure) (image
adapted from Baino et al. [21]© Springer), (b) MCM-41 sphere on a fluoroapatite scaffold (dipping method) (image adapted from Vitale-
Brovarone et al. [37]© Springer), (c) MBG particles deposited on a wollastonite-containing scaffold (EPD) (image adapted from Fiorilli et al.
[43]© Springer), (d) CaSiO3 scaffold coated with a PLGA/MBG composite layer (dipping method) (image adapted from Shi et al. [46]).
2.1 Glass-coated porous polymers
The first example of a bioactive and resorbable glass-
coated polymeric scaffold was reported by Roether et
al. [18], who fabricated macroporous poly(DL-lactide)
(PDLLA) foams coated with 45S5 Bioglassr particles
(mean size below 5 µm). Stable and homogeneous glass
coatings were produced by two processing methods, i.e.
a slurry-dipping technique (in conjunction with a pre-
treatment of the PDLLA foam in ethanol) and the elec-
trophoretic deposition (EPD), which exploits the move-
ment of charged particles suspended in a solution under
an electric field with the aim of depositing them on a sub-
strate [19]. In vitro bioactivity studies revealed the forma-
tion of a surfaceHA layer, the thickness ofwhich increased
with increasing time in simulated body fluid (SBF).
45S5 Bioglassr-coated polyurethane and
polyurethane/PDLLA foams were also prepared by dip-
ping cycles to improve the bioactivity of the polymeric
substrate [20]. A similar approach was reported by Baino
et al. [21] who coated polyurethane foams with a layer of
CEL2 glass particles (Fig. 1a) that imparted high bioactivity
to the otherwise inert polymeric scaffold and significantly
increased the Young’s modulus of the structure compared
to the uncoated material (1.35 vs 0.12 MPa).
An interesting application of bioactive glass coat-
ings on a porous polymeric template was recently re-
ported by Cabanas-Polo et al. [22] who fabricated 3D scaf-
folds by the foam replication technique combining sol-
gel and EPD process. In this approach, the sol precur-
sor molecules were found to be positively charged and,
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Table 3: Overview of bioactive glass-based coatings on joint prostheses and surgical devices.
Coating
material
Substrate/implant Method of application Coating function Referencesa
SCNA Alumina cup Dipping or airbrush
spraying + firing
Joining [53–55]
S57A7 Alumina/zirconia cup Airbrush spraying + firing Joining [56]
S50P3 Alumina cup Optimized sponge replica
method
Improved bioactivity [56]
S50B2 Alumina/zirconia cup Optimized sponge replica
method
Improved bioactivity [57]
45S5
Bioglassr
Porous titanium Infiltration Improved bioactivity [60]
Stainless steel Atmospheric plasma
spraying
Improved bioactivity [62]
Polymeric sutures Dry powder pressing,
dipping
Improved bioactivity [70–73]
Nitinol wire EPD Improved bioactivity [74]
Biovetror Titanium alloy femur stem Plasma spraying Improved bioactivity [59]
52S Ti6Al4V dental screw Plasma spraying Improved bioactivity [61]
Chitosan/45S5
Bioglassr
Stainless steel EPD Improved bioactivity [63, 64]
Titanium alloy foams EPD Improved bioactivity [67]
Chitosan/45S5
Bioglassr/
silver
nanoparticles
Stainless steel EPD Improved bioactivity,
antibacterial effect
[68]
Alginate/45S5
Bioglassr
Stainless steel EPD Improved bioactivity [65]
PEEK/45S5
Bioglassr
Ti-6Al-7Nb EPD Improved bioactivity [66]
Nitinol wire EPD Improved bioactivity [75]
PEEK/45S5
Bioglassr/
silver
nanoparticles
Stainless steel EPD Improved bioactivity,
antibacterial effect
[69]
58S/TiO2 Nitinol nail Dipping Improved bioactivity [76]
a References follows numbering in the main text.
upon electrophoresis, travelled from the surroundings of
the counter-electrode to the cathode (a Ni wire fixed to a
polyurethane non-conductive sponge), thereby creating a
fairly homogeneous impregnation of the porous substrate.
At the end of the process, the sol-coated polymeric tem-
plate were left to dry and thermally-treated to obtain a
glass (61S31C)-derived positive replica of the foam.
Besides being used as a coatingmaterial on preformed
polymeric scaffolds, biomedical glasses have been widely
employed over the last 15 years for the production of a vari-
ety of porous composites in which the inorganic particles
are usually dispersed as bioactive and/or reinforcing in-
clusions in an organic matrix; the interested reader is ad-
dressed to some comprehensive reviews on this topic [9,
23, 24].
2.2 Glass-coated inorganic scaffolds
Bioactive glass coatings have been deposited on a wide
range of porous inorganic substrates, including nearly-
inert ceramics, hydroxyapatite and metals, to impart
added value to the substrates, primarily bioactivity.
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Table 4: Overview of glass-based coatings on medical implants in contact with soft tissues.
Coating
material
Substrate/implant Method of application Coating function Referencesa
2Ag-60S Polymeric sutures Dipping Antibacterial effect [81, 82]
3Zn-42S Polymeric sutures Dipping Antibacterial effect [84]
45S5
Bioglassr
Polyethylene orbital
implant
Dipping Improved angiogenesis
(fibrovascularization)
[88, 89]
Silicone tube (catheter) Patented technology
involving a pre-treatment
of the tube in
hexane/silicone solution
Soft tissue fixation [100, 101]
5Cu-MBG HA orbital implant Dipping + calcination Antibacterial properties
and drug release (release
of Cu2+ ion and ofloxacin)
[90]
A/W Titanium “skirt” (flange) of
a keratoprosthesis
Dipping + firing Improved biocompatibility
with ocular tissues
[94]
SiO2/Ag
nanoclusters
PMMA ocular prosthesis Radio-frequency
sputtering
Antibacterial properties
(Ag+ ions)
[91, 92]
Polypropylene mesh for
hernia repair
Radio-frequency
sputtering
Antibacterial properties
(Ag+ ions)
[98]
a References follows numbering in the main text.
Miao [25] coated the struts of alumina foams with a
thin filmof lanthanum-doped alumino-silicate (LAS) glass
to fill micropores and, therefore, improve the mechani-
cal properties of these highly-porous substrate (above 80
vol.%). However, the resulting LAS-modified ceramic scaf-
folds exhibited no ability to bond to bone tissue; there-
fore, a 58S glass layer was then applied by dipping to im-
part bioactivity to the otherwise inert porous ceramics.
The twice-coated and sintered scaffolds exhibited apatite
forming ability upon contactwithbiological fluids and suf-
ficient compressive strength to be proposed for maxillofa-
cial reconstruction.
A similar approach was followed by Liu et al. [26]
who applied a layer of 58S glass on the struts of alu-
mina/zirconia (80 : 20 vol.%) composite scaffolds by dip
coating. The glass-coated macroporous composite had a
total porosity comparable to that of cancellous bone (60-
66 vol.%), well-interconnected pores with large sizes (1-
2 mm), adequate compressive strength for safe manip-
ulation during surgery (5-8 MPa), and good bioactivity
as demonstrated by the formation of a surface HA layer
within 24 h in SBF.
45S5 Bioglassr coatings on porous SiC have also been
produced by EPD; a postdeposition thermal treatment was
applied to improve the cohesion of glass particles, in order
to obtain a uniform coating with excellent coverage of the
porous SiC struts [27]. In vitro studies carried out in SBF
revealed the formation of a surface apatite layer, which
demonstrates that even fully bioinert SiC can be “bioac-
tivated” by the presence of a glass coating of suitable com-
position.
Bioactive glass coatings were also applied on os-
teoconductive but non-osteoinductive calcium phosphate
scaffolds to improve their biological performances. Jun
et al. [28] fabricated porous HA foams via the sponge
replica method and coated them with a bioactive A/W
glass-ceramic layer by a dipping procedure. It was ob-
served that all of the scaffolds retained a highly porous
structure (above 93 vol.%) with well-interconnected pores
and the A/W coating significantly increased the compres-
sive strength of the HA scaffolds due to the formation of a
dense, strong and smooth glass-ceramic “sleeve” around
the weak HA struts (1.0 vs. 0.1 MPa). The in vitro bioactive
behavior of the scaffolds was markedly improved by the
glass-ceramic coating as demonstrated by the formation
of a surface nano-crystalline apatite layer as well as the
higher proliferation rate and alkaline phosphatase activity
of osteoblast-like cells compared to the uncoatedmaterial.
Highly porous (83 vol.%) scaffolds of bovine-derived
HA were also coated with a thin layer of 58S glass by a
prolonged dipping procedure to improve the compressive
strength of the material (from 0.22 to 1.49 MPa) [29].
A significant improvement of the mechanical proper-
ties of biphasic calcium phosphate scaffolds was achieved
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by applying polycaprolactone (PCL)/nano-sized 58S
glass composite coatings containing various amounts (1-
90 wt.%) of inorganic phase (compressive strength: 0.2-1.5
vs. 0.1 MPa, elastic modulus: 20-50 MPa vs. 15 MPa) [30].
After examining the fracture surfaces, the authors of this
study reported that there was no sign of detachment of the
nanocomposite layer from the substrate surface, which
indicates a strong interfacial bond of the coating to the
calcium phosphate material. Furthermore, the nanocom-
posite layer stretched considerably before breaking off
and the coating presented a ductile fracture surface due
to the excellent ductility of PCL [30]. Fabrication of bioac-
tive glass and, in general, bioceramic monolithic coat-
ings on metallic substrates is challenging due to a series
of problems associated with high-temperature sintering
required for the consolidation of the bioactive layer, in-
cluding the risk of oxidation of the metal surface and TEC
mismatch [10]. Therefore, there is increasing interest in
the development of polymer/glass coatings that can ad-
here to the metallic substrate at low temperatures. In this
regard, a multilayer coating composed of PCL and gelatin
reinforced with 64S glass particles has been applied on
the surface of magnesium (Mg) scaffolds by means of a
freeze-drying process [31]. The presence of the bioactive
coating induced the growth of a surface apatite layer on
the scaffold struts and reduced the degradation rate of
the substrate material: in fact, it was observed that un-
coated Mg scaffolds were fully degraded after 3 days in
SBF, whereas about 87 wt.% of PCL/gelatin/glass-coated
samples remained after immersion for 14 days. Thiswas an
important finding that could expand the biomedical ap-
plications of Mg scaffolds and implants, the use of which
is very limited in bone tissue engineering due to the too
fast degradation of the metal in contact with biological
fluids to allow an adequate support to hard tissues [32].
2.3 Hierarchical scaffolds with a
mesoporous coating
Another key added value that can be imparted to bone
tissue engineering scaffolds by means of an appropriate
coating is the ability to incorporate anddeliver therapeutic
agents in a controlled way according to predetermined re-
lease kinetics. Inmost cases, polymeric or polymer-coated
ceramic scaffolds have been proposed for this purpose
since drugs can be incorporated in the organic phase and
subsequently released as the polymer degrades [33].
The advent of silicate mesoporous materials, which
being amorphous can be formally considered as SiO2-
based glasses, revolutionized the field of drug release over
the last two decades allowing a finely controlled release
of biomolecules to be successfully achieved from inor-
ganic matrices, too [34]. Using silica mesoporous mate-
rials for the fabrication of multifunctional hierarchical
scaffolds was proposed in the attempt to combine the at-
tractive properties of bioactive glass-derived macroporous
scaffolds, i.e.mechanical support to host and regenerated
bone and stimulation of bone cells towards osteogenesis,
with the drug uptake/release ability supplied by themeso-
porous material. The first prototype of such a construct
was developed by Cauda et al. [35] who coated bioactive
glass-ceramic scaffolds with a thin layer of SBA-15 spheres
(mesopores within 5-8 nm arranged according to a hexag-
onal symmetry). This early study was then extended to
MCM-41 (Fig. 1b), which possesses narrower pore size (2-
3 nm, hexagonal symmetry of pore arrangement) com-
pared to SBA-15 [36–38]; in both cases, the silica meso-
porous coating deposited on scaffold struts was found to
play a key role in enhancing the drug adsorption abil-
ity of the porous construct. A similar approach was also
proposed by Boccardi et al. [39] who synthesized sub-
micronic MCM-41 spheres directly on a 45S5 Bioglassr-
derived foam through a modified Stöber method.
From the viewpoint of regenerative medicine, the ma-
jor limitation of pure SiO2 mesoporous materials is their
moderate reactivity in biological environment: in fact, al-
thoughMCM-41 and SBA-15 were shown able to form a sur-
face apatite layer upon prolonged immersion in SBF [40,
41], the reaction kinetics are too slow to consider them as
effective bone-bonding materials. With these concerns in
mind, researchers introduced other oxides (primarily CaO
and P2O5) in the composition of mesoporous materials to
obtain nano-textured bioactive glasses with exceptional
apatite forming ability [42]. Fiorilli et al. [43] exploited the
electrophoretic mechanism to deposit mesoporous bioac-
tive glass (MBG) particles onto the struts of a wollastonite-
containing macroporous scaffold (Fig. 1c) to combine the
excellent bioactivity of the mesoporous phase with the
high mechanical strength (above 15 MPa under compres-
sive loads) of the glass-ceramic skeleton that, without the
coating, was a nearly-inert material.
For the same purpose, spin coating method was ex-
perimented by Zhang et al. [44] to deposit a thin layer
(about 100 nm) of MBG on the struts of a 3D-printed β-
TCP scaffold to improve its bone forming ability; early
in vivo tests (rabbit model) revealed that this hierarchi-
cal macro-mesoporous construct significantly improved
the mineralization ability, attachment/viability and os-
teogenic/angiogenic gene expression of osteoblastic cells
as well the formation of new bone compared to the un-
coated material.
Brought to you by | Interscientia S.A.S.
Authenticated
Download Date | 4/26/17 9:17 AM
8 | F. Baino and E. Verné
It is worth pointing out that usingMBG as a coating on
a strong substrate also allows overcoming the mechanical
limitations ofmesoporousmaterials (dramatic brittleness)
due to the inherent nanoporosity [45].
Shi et al. [46] fabricated MBG/poly(lactic-co-glycolic
acid) (PLGA)-coated CaSiO3 scaffolds by dipping the
macroporous template in a PLGA solution with different
amounts of suspended nano-sizedMBG particles (Fig. 1d).
The mechanical strength of MBG/PLGA-coated scaffolds
were greatly improved due to the addition of nano-sized
MBG particles compared to uncoated and PLGA-coated
CaSiO3 scaffolds (1.5-2 vs. 0.4 MPa). Furthermore, the
bioactive coating enhanced the in vitro mineralization
ability, the proliferation and early cell differentiation of os-
teoblasts, and the mesoporous channels inside the MBG
particles allowed a controlled release of ibuprofen to be
achieved.
Although the above-mentioned experimental devices
were usually found functional for the intended scope (e.g.
improved bioactivity, drug release), most approaches fol-
lowed to deposit a mesoporous layer on the struts of a
ceramic/glass-ceramic scaffolds (dipping, EPD) still need
to be optimized to improve the coating uniformity and ho-
mogeneity (Figs. 1c and 1d).
3 Coatings on endoprostheses and
devices for surgical fixation
3.1 Orthopaedic and dental implants
Thehip prosthesis has been themost active area of joint re-
placement research and development since the beginning
of the 20th century. Today, the most commonly used bear-
ing couples in hip joint replacements consist of a cobalt-
chrome (CoCr) alloy (femur head) articulating against
anultrahigh-molecular-weight polyethylene cup (acetabu-
lar component). Ceramics (alumina and alumina/zirconia
composites) have been increasingly used as a valuable al-
ternative to metal-on-polyethylene bearing couple due to
excellent anti-wear properties and bioinertness [47]. The
polymeric or ceramic prosthetic acetabular cup is fixed
to the patient’s bone by means of a metal-back provided
with screws or anchoring flanges, with or without the use
of an acrylic cement. The use of HA as a bioactive coat-
ing on the metal-back has been experimented, but the re-
sults and actual benefits seem to be still controversial [48].
Griss et al. [49] implanted a 45S5 Bioglassr-coated alu-
mina total hip prosthesis (acetabular cup and femur stem)
in sheep and found that, although new bone formation
was observed at the bone-implant interface, problems of
instability occurred in the long-term. Similar results and
problems were reported by Hamadouche et al. [50] who
experimented alumina implants coated by a sol-gel glass
in rabbits. While in these early studies monolithic glass
coatings were employed, Verné et al. [51] first claimed the
concept that a single-piece ceramic acetabular cup can be
fixed to the patient’s bone by means of a porous coating
made of bioactive glass. This novel bone-like glass coat-
ing aims to overcome the current limitations associated to
implant modularity (need for a perfect assembling of the
cup into the metal-back during surgery), traumatic fixa-
tion and toxicity due to metal ion release and/or cement
degradation. This novel prosthetic acetabular cup is con-
stituted by three layers, i.e. an alumina/zirconia composite
substrate, a bioactive glass-based trabecular coating and
a glass-derived interlayer with the aim of improving the
adhesion between the bioceramic cup and the trabecular
coating [52]. The key element of this 3-layer system is the
outer bone-like coating, as newbone is expected to grow in
vivowithin its 3D network of highly interconnectedmacro-
pores, thereby creating a tight interfacial bond between
prosthetic cup and host bone. Fabrication of an early pro-
totype of such implant was a highly challenging task: in
this regard, optimized dipping procedures and airbrush
spraying of glass slurries were experimented to manufac-
ture the non-porous interlayer on the curved surface of
the cup (Fig. 2a) [53, 54], while the outer trabecular coat-
ing was successfully produced by properly adapting the
sponge replica method to the 3D radial geometry of the
prosthesis (Figs. 2b and 2c) [55–57]. In these studies, the
issue of estimating reliably the adhesion strength of the
bioactive coating to the curved substrate was also tackled:
specifically, the recommendations of the relevant ASTM
standard dealing with pull-out tests on flat samples [58]
were properly adapted for a “nearly-flat” geometry and
appropriate testing tools were manufactured for this pur-
pose [53].
In the field of metallic implants, a special mention
should be dedicated to the study reported by Alonso-
Barrio et al. [59] who implanted clinically (70 human pa-
tients) titanium-based prosthetic femur stems having the
proximal two-thirds coated with a 80-µm thick layer of
Biovetror. Survival rate for this stem was 91.4% after a
8-year follow-up, and clinical evaluation including pain,
mobility and gait revealed that results were excellent or
good in 77% of cases, whereas 23% of patients had fair or
poor results. Interestingly, the authors of this study con-
cluded that, however, Biovetror coating produced worse
osteointegration compared to plasma-sprayed HA due to
the appearance of a fibrous interface with a macrophage
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Figure 2: Bioactive glass coatings on alumina/zirconia composite acetabular cups for hip joint prosthesis: (a) SCNA-derived coating pro-
duced by a slurry-dipping procedure (left: “green” sample, right: sintered coating), (b) and (c) three-fourth views of a full prototype with a
S50B2-derived trabecular coating produced by an optimized sponge replica method (images adapted from Baino et al. [57]© Elsevier).
foreign body reaction, less new bone, a significant delay
in bone maturation and insufficient mineralization of the
newly-formed bone.
More recently, Drnovšek et al. [60] infiltrated the outer
porous titanium layer of Ti6Al4V cylindrical implants (di-
ameter 3 mm, length 6 mm) with 45S5 Bioglassr particles
with size from 100 nm to 1 µm. The thickness of the vac-
uum plasma-sprayed porous titanium layer was 300 µm,
with interconnected pores in the range of 20 to 100 µm.
The implants with or without the bioactive glass coating
were inserted bilaterally in tibial holes of ten New Zealand
white rabbits. After ten weeks in vivo, 45S5 Bioglassr was
fully resorbed and about 38% of the pores throughout the
thickness of the porous titanium layer were filledwith new
bone. In the absence of the bioactive coating, only 22% of
the poreswere filled bynewbone,whichwas foundmostly
in the outer part of the porous titanium layer. Although
the observed percentage of pores occupied by new bone
in the glass-coated implants seems not to be exception-
ally high (38%), the increase from 22% to almost a dou-
ble value demonstrates the key role playedby the bioactive
layer in stimulating bone ingrowth during the first weeks
after implantation.
In another interesting study, Schrooten and
Helsen [61] combined an experimental approach with fi-
nite element analysis to evaluate the adhesion strength of
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Figure 3: 45S5 Bioglassr-coated Vicryl sutures produced by slurry dipping before (a) and after soaking for 28 days in SBF (b) (images
adapted from Bretcanu et al. [72]© Springer).
52S glass coatings applied on Ti6Al4V dental implants by
means of plasma spraying. It was shown that the coating
could withstand an externally generated tensile stress of
47 MPa without any damage; adhesion tests performed
after 2 months in SBF revealed that the coating adhesion
strength decreased of about 10% but the glass-Ti6Al4V
interface remained fully intact at all times.
Atmospheric plasma spraying was also experimented
to produce 45S5 Bioglassr coatings on AISI 304 steel flat
substrates [62].
A relatively recent and highly promising area of re-
search concerns the development of coating systems in-
volving a polymer matrix with bioactive glass inclusions.
The use of these coatings is particularly attractive in
the case of metallic implants as there is no need for a
high-temperature thermal treatment, which is necessary if
monolithic glass or ceramic coatings are used but is often
incompatible with metal substrates. These “soft” compos-
ite coatings can also create a better transition between the
metallic implant and the bone.
EPD proved to be a valuable strategy to pro-
duce such type of coatings on both flat surfaces
(e.g. 45S5 Bioglassr/chitosan [63], Sr-/Zn-doped 45S5
Bioglassr/chitosan [64] and 45S5 Bioglassr/alginate
composite coatings on AISI 316L stainless steel [65],
45S5 Bioglassr/polyetheretherketone (PEEK) on Ti-
6Al-7Nb alloy [66]) and 3D porous structures (45S5
Bioglassr/chitosan coatings deposited on Ti-4Al-6V
foams [67]). Antibacterial 45S5 Bioglassr/polymer-based
layers embedding silver nanoparticles were also produced
on AISI 316L stainless steel by EPD [68, 69].
3.2 Devices for surgical fixation
Application of a bioactive glass coating on polymeric
meshes is useful to induce the formation of a nano-
crystallineHA layer on the surface of the suture, the degra-
dation of which can therefore be designed andmodulated.
Stamboulis et al. [70] produced 45S5 Bioglassr coatings
(particle size below 5 µm) on polyglactin 910/polydiox-
anone surgical meshes by means of dry powder pressing
or slurry-dipping processes and demonstrated the excel-
lent in vitro bioactivity of the surface-modified polymeric
sutures. Commercial Vycrilr sutures were also coated
with 45S5 Bioglassr particles by means of similar pro-
cedures (Fig. 3a) [71], and it was noted that the slurry-
dipping process gave the better results in terms of uni-
formity/reproducibility of the coating (thickness 15-20 µm)
and bioactive behavior (faster kinetics of HA formation in
SBF), although the suture showed a degraded structure
after immersion for 28 days in SBF (Fig. 3b) [72]. Inter-
estingly, these glass-coated sutures exhibited a decrease
in tensile strength compared to uncoated ones (385 vs.
467 MPa) [73]: the possible explanations were associated
to mechanical damage of the suture surfaces by the hard
inorganic particles upon coating preparation and/or the
possible infiltration of glass particles into the voids of the
braided structure of the suture.
Although this application was initially developed in
the context of bone repair due to the bone-bonding ability
of bioactive glasses, recent studies have been addressed
to wound healing and, therefore, this topic is discussed in
more detail in the section 4.1.
Besides polymeric sutures, other devices used for the
surgical fixation of implants, such as metal wires, have
been coatedwith abioactive glass layer. In this regard, EPD
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was found a very suitable technique to deposit monolithic
45S5 Bioglassr [74] and PEEK/45S5 Bioglassr compos-
ite coatings [75] on shape-memory nickel-titanium (Niti-
nol) wires. PEEK is suitable for a number of medical de-
vice applications since it combines excellent chemical and
hydrolysis resistance, high strength and excellent tribo-
logical properties; bioactive glass particles were incorpo-
rated into the coating to impart bioactivity as an extra-
functionality. Apost-EPDprocess atmoderate temperature
(340∘C for 20 min, heating rate 300∘C/h) was applied to
improve the densification and adhesion of the coating to
the substrate (final thickness: 15 µm) [75].
Esfahani et al. [76] dip-coatedNitinol nailswith a com-
posite layer made of nano-sized 58S particles (50-60 nm)
and titanium oxide (TiO2) produced via a sol-gel route. It
was observed that the presence of glass particles in the
TiO2 matrix enhanced gradually the hardness of the coat-
ing and direct pull-out test recorded a coating-substrate
bonding strength larger than 16MPa. Furthermore, in vitro
bioactivity studies revealed the formation and growth of
HA agglomerates on the surface of the 58S/TiO2-coated
Nitinol alloy.
4 Coatings on implants for
non-osseous applications
Until the early 1980s biomaterials scientists believed that
only calcified tissues could form a bond to bioactive mate-
rials.Wilson et al. [77] first showed thatmelt-derivedbioac-
tive glasses in the SiO2–CaO–Na2O–P2O5 system can also
bond to soft collagenous tissues when the material com-
position exceeds 52 wt.% of SiO2. Today bioactive glasses
are still mainly employed for hard tissue repair and regen-
eration in the clinical practice, but especially in the last
decade awide range of non-osseous tissue engineering ap-
plications has emergedwhich seemed impossiblewhen re-
search began. The interested reader is addressed to a cou-
ple of recent reviews that provide a comprehensive picture
of the potential of biomedical glasses in contact with soft
tissues [78, 79].
4.1 Wound healing
Wound healing represents a major challenge in medicine
and is commonly associated to a number of clinical sce-
narios including skin regeneration, chronic wounds (e.g.,
non-healing diabetic ulcers) and surgical sutures. The skin
plays an important role in the prevention of infections
from pathogens; once a trauma is suffered, the damaged
skin should be immediately covered with a dressing ma-
terial able to maintain a moderately moist environment
for regeneration of the skin, and prevent infection by ex-
erting an antibacterial effect [80]. Blaker et al. [81] coated
resorbable polymeric sutures with silver-doped bioactive
glass (2Ag-60S) powder by a dipping procedure and re-
ported the in vitro bioactive behavior and bactericidal ef-
fect of the composite. In a next study, Pratten et al. [82]
carried out in vitro experiments using Staphylococcus epi-
dermidis to compare the antimicrobial activity of commer-
cialMersilkr sutures coatedwith 45S5 Bioglassr and 2Ag-
60S powder and reported that Ag-doped sutures showed a
significantly greater effect in limiting bacterial attachment
compared to 45S5 Bioglassr-coated and as-such sutures.
Besides silver, which is known as a potent antibacterial
agent [83], other elements such as zinc have been used to
dope bioactive glasses. Salah Ahmeed et al. [84] recently
reported the in vitro antibacterial activity of Mersilkr su-
tures coated with 3Zn-42S bioactive glass against Staphy-
lococcus aureus, Streptococcus mutans and Lactobacillus.
A comprehensive overview of the use of biomedical
glasses for wound healing, not restricted to bioactive coat-
ings, has been published by Shah Mohammadi et al. [85].
4.2 Ocular applications
Due to its biocompatibility and transparency to visible
light, glass has been used for centuries in ophthalmol-
ogy for fabricating external lenses to correct refractive de-
ficiencies of the eye. In these “traditional” applications,
glass has been employed as an optical element of oph-
thalmic devices; in recent years, some highly innovative
applications of bioactive glasses and glass-ceramics have
emerged to impart key added values to ocular implants,
such as angiogenesis and antibacterial properties [86].
Orbital implants are porous or non-porous devices
that aim to replace the orbital volume after surgical re-
moval of the globe (evisceration, enucleation) due to ma-
lignant tumors, oculo-orbital traumas or untreatable in-
fections [87]. The most commonly used orbital implants
are porous spheres made of HA, polyethylene or alumina
inwhich fibrovascular tissue is expected to growpostoper-
atively. A novel implant, constituted by a sphere of porous
polyethylene coated by a thin layer of 45S5 Bioglassr, has
been recently introduced on themarket and sold under the
commercial name of Medpor-Plus. Naik et al. [88] investi-
gated the fibrovascular in-growth of Medpor-Plus orbital
implants compared to conventional porous polyethylene
spheres in ten enucleatedpatients and founda statistically
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Figure 4: Ag nanocluster/SiO2 glass coating applied by radio-frequency sputtering on (a-c) a PMMA ocular prosthesis (images adapted from
Baino et al. [91]© Elsevier) and (b) a polypropylene prosthesis for hernia repair (image adapted from Muzio et al. [98]©Wiley).
significant increase in the rate of fibrovascularization of
glass-coated polyethylene implants under MRI investiga-
tions. In a more recent study, Ma et al. [89] examined the
overall postoperative outcomes of 170 enucleated patients
receiving a Medpo-Plus implant and reported an overall
success rate of 94.7%.
Other authors applied surface coatings to orbital im-
plants in order to impart an antibacterial effect. Ye et
al. [90] coated HA implants with a copper-containingMBG
(5Cu-MBG) coating to combine the bactericidal effects of
Cu2+ ions released as the coating degrades and ofloxacin,
an antiseptic drug that was encapsulated in the glass
mesopores. Preliminary in vitro analyses validated the
twofold effect of the proposed system against both gram-
positive (Staphylococcus aureus) and gram-negative bac-
teria (Escherichia coli), thus opening new perspectives for
the prevention and treatment of implant-related ocular in-
fections.
Silver nanocluster/SiO2 glass composite coatings have
been also deposited via radio-frequency sputtering on the
surface of poly(methyl methacrylate) (PMMA) ocular pros-
theses to be coupled with orbital implants (Figs. 4a-4c),
and it was reported that the material elicited a potent an-
tibacterial effect in vitro against Staphylococcus aureusdue
to the sustained release of Ag+ ions [91, 92].
Bioactive glass coatingshavealso founda sporadic ap-
plication in the manufacturing of artificial corneas (ker-
atoprostheses), which are implanted when transplant of
corneal tissue is unfeasible [93]. Keratoprostheses are ba-
sically constituted by an optical core (transparent PMMA
cylinder) that is anchored to host tissue by a porous
“skirt”. Linnola et al. [94] deposited a bioactive A/W glass-
ceramic coating on a keratoprosthetic titanium skirt in
the attempt to avoid the ingrowth of epithelium into the
anterior chamber, which could open a canal for infec-
tions, cause the extrusion of the prosthesis and induce
postoperative glaucoma. The outcomes of A/W-coated and
uncoated kerathoprostheses were evaluated in 22 New
Zealand albino rabbits after enucleation (11 for each of the
two groups): a predominant epithelial ingrowth was ob-
served with the uncoated devices, which supported the
idea that a bioactive coating was able to rapidly anchor
the prosthesis to the corneal tissue thereby preventing ep-
ithelial down-growth from the surface along theprosthesis
into the interior of the eye. However, the A/W coating was
prone to degradation in the long-term and tended to de-
tach from the titanium substrate; perhaps these were the
major reasons why the studies, although promising, were
discontinued.
Brought to you by | Interscientia S.A.S.
Authenticated
Download Date | 4/26/17 9:17 AM
Bioactive glass coatings | 13
A passivation layer of pure SiO2 glass (thickness
500 nm) was also applied on the Si electrodes of an
early prototypeof artificial retina [95]. Animal experiments
in rabbits and pigs revealed a degradation of the SiO2
layer accompanied by pit corrosion of the Si substrate for
implantation periods above 6 months. In order to over-
come this drawback, the researchers’ interest was then ad-
dressed to other materials to fabricate both the substrate
(e.g. nanoporous TiN) and the passivation layer (high-
performance polymers) [96].
4.3 Prostheses for hernia repair
A number of biological and synthetic prostheses are com-
mercially available for abdominal hernia repair; the most
commonly used devices are made of polypropylene and
comprise a single polymeric mesh or a two-layer sys-
tem [97]. Very recently, Muzio et al. [98] deposited a silver
nanocluster/SiO2 glass composite coating on a polypropy-
lene prosthesis comprising a porous mesh in contact with
the parietal side and a 70-µm thick smooth layer that pre-
vented adhesion with intestine and viscera (Fig. 4d). Only
themesh layer, beingmore prone to bacterial colonization
due to its wrinkled surface structure, was sputter-coated
with the silver nanocluster/SiO2 glass film (thickness of
few tens of nanometres). During in vitro experiments, the
coating promoted the growth of human mesothelial cells,
the role of which is crucial in healing the abdominal wall,
and exhibited a bactericidal effect against Staphylococcus
aureus due to the release of Ag+ ions.
4.4 Fixation of percutaneous catheters
Catheters for peritoneal dialysis are made of highly bio-
compatible polymers, such as silicone, which is success-
ful in minimizing the foreign body reaction and enhanc-
ing the longevity of the device [99]. Typically, a thin fi-
brous capsule develops around the catheterwithout a tight
adhesion. Therefore, a space between the device and the
interposed fibrous layer may exist, which allows bacte-
rial migration from the percutaneous site into the peri-
toneum with serious consequences for the patient. Poly-
meric cuffs can be used for anchorage, but they may be
susceptible to infections that are difficult to eradicate and
can lead to the loss of the catheter. The capability of 45S5
Bioglassr to bond to soft collagenous tissueswas the basis
of the pioneering work carried out by Marotta et al. [100],
who patented a technology to produce stable and well-
adherent bioactive coatings on silicone catheters by apply-
ing a pretreatment in hexane/silicone solution to the outer
surface of the polymeric tube. Ross et al. [101] implanted
segments of 45S5 Bioglassr-coated silicone tubes (length
2.5 cm) in rats, using uncoated tubes as controls. Histolog-
ical analysis of the tissue-implant interfaces at 2, 4 and 6
post-insertion weeks showed that uncoated tubes had no
adherence to the surrounding tissues with a physical sep-
aration of about 50 µm, whereas the glass-coated devices
were tightly fixed to the soft tissues. Although this early
animal study demonstrated that 45S5 Bioglassr coatings
enhanced the stabilization of the device, surprisingly no
other report has been found in the literature on this topic
and the researchwas apparently discontinued.On the con-
trary, this research area would deserve careful and inten-
sive investigation in the future to achieve rapid and stable
interfacial bonding of catheters and other percutaneous
devices for a variety of clinical needs.
5 Conclusions and open challenges
As witnessed by the large amount and variety of studies
reviewed in this article, in the last years the range of appli-
cations of bioactive glass coatings expanded dramatically
beyond the “traditional” bone-bonding ability of orthope-
dic and dental implants. Glass-based coatings have been
successfully applied on 3D porous scaffolds for tissue en-
gineering aswell as on devices in contact with soft tissues,
such as ocular implants, polymeric meshes for wound
dressing and percutaneous catheters. Along with new ap-
plications, new deposition techniques, e.g. EPD and radio-
frequency sputtering, have been experimented to produce
well-adherent and long-lasting coatings on a number of
non-porous and porous metallic, ceramic and polymeric
substrates. Every method has its advantages and limita-
tions, and it is impossible to define universally the “best”
processing strategy as this choice strongly depends on the
specific nature of the biomedical device to coat and the
characteristics of the coating material.
Likewise, it is not easy to compare reliably the perfor-
mance of different glass coatings applied on non-flat sub-
strates, since very often no standard methods or proce-
dures havebeen established to characterize bioactive glass
coatings deposited on “real” implants. For example, the
adhesion strength of the coating to the substrate is a fun-
damental parameter, but international recommendations
exist only for testing flat samples. Therefore, available
standards are often modified, adapted or implemented
case by case, whichmakes a direct comparison among the
data available in the literature difficult to do.
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Another key issue is the assessment of the long-term
stability of bioactive coatings in vivo, i.e. under “real”
working conditions. In fact, it is well known that the hu-
man body is a highly reactive environment from chemi-
cal and biological viewpoints, and thus studies on long-
lasting performance of the coatings are necessary to in-
vestigate the response of materials after a long time of
implantation; however, there still is a paucity of contri-
butions addressed to this topic in the literature. Investi-
gation of in vivo performance of biomedical implants is
a long, time-consuming and expensive way that begins
with animal studies; it is impressive that, except for few
cases (e.g. Biovetror-coated femur stems), the majority of
glass-coated implants reviewed in this article have not yet
been involved in early human trials and just a single de-
vice (45S5 Bioglassr-coated polyethylene orbital implant,
Medpor-Plus) has been cleared via the 510(k) process by
FDA in 2002 and then marketed worldwide.
In summary, there is interest in fabricating novel
bioactive glass and composite coatings that can carry
added values to scaffolds and implants, aswell as in devel-
oping more reliable characterization methods to test and
compare the performance of these coatings. The increas-
ing need for biomedical devices to meet the requirements
of an ageing population will indeed urge the research in
the field of bioactive glass coatings, which will bring fur-
ther prestige to the long history of glass in medicine.
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